Rewind to Stocks::Stuffer posting one 02012.03.29 titled: "Illumina Needs to Say no, nO, NO!". Here's the second paragraph from that posting.
Illumina (ILMN) closed yesterday (02012.03.28) at $49.88. 52-week range: $25.57 - $79.40. Roche's initial offer was $44.50 and their new offer is $51. I don't want sell our ILMN shares at $51 because I think they are worth more than that; therefore, this is potentially bad news because other investors might disagree with my opinion and be happy cashing out at $51. I continue to believe Roche is trying to buy Illumina on the cheap.
Yesterday (02014.01.14) Illumina issued a press release that started with the following.
Illumina, Inc. (ILMN) today broke the ‘sound barrier’ of human genomics by enabling the $1,000 genome. This achievement is made possible by the new HiSeq X Ten Sequencing System. This platform includes dramatic technology breakthroughs that enable researchers to undertake studies of unprecedented scale by providing the throughput to sequence tens of thousands of human whole genomes in a single year in a single lab.
I continue to believe that we have entered into the Age of Genomics.
No comments:
Post a Comment